Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
- Conditions
- Atrial FibrillationAtrial Fibrillation, PersistentAtrial Fibrillation Paroxysmal
- Registration Number
- NCT04544397
- Lead Sponsor
- Luigi Sacco University Hospital
- Brief Summary
The purpose of this study is to collect data on laser ballon (2nd gen) systems for catheter ablation for AF, in order to determine the safety and the efficacy of this technique.
Moreover, the investigators aim to determine the short and long term outcomes of pulmonary vein isolation evaluating arrhythmia recurrence, especially using continuous rhythm monitoring with implantable loop recorders (ILR).
- Detailed Description
LIGHT-AF is an observational, multicentric study designed to collect pre-procedural, procedural and follow-up data of consecutive patients that underwent catheter ablation for AF with laser ballon (2nd gen system). A number of 3 enrolling centers is estimated with an overall number of about 100 patients. A minimal follow-up of 3 months is required before analyzing clinical outcomes. The data analysis will focus on implant outcomes and early, mid and long-term recurrence of AF, evaluated with intracardiac rhythm monitoring.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Age >/= 18 years
- Patients with paroxysmal, persistent or long-standing persistent AF
- Patients able to provide written informed consent or have informed consent as provided by a legal representative
- Age < 18 years
- Patients unable or unwilling to receive oral anticoagulation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AF recurrences 2 years Time to first recurrence of symptomatic or asymptomatic atrial tachyarrhythmias
- Secondary Outcome Measures
Name Time Method Arrhythmia burden 2 years Percentage of overall time in AF
Redo ablation procedures 2 years Patients requiring a redo ablation procedure, after the first one
Adverse events 2 years Procedural mortality or other adverse events related to the procedure
Trial Locations
- Locations (3)
IRCCS Policlinico San Donato
🇮🇹San Donato Milanese, Milano, Italy
Ospedale Luigi Sacco - Polo Universitario
🇮🇹Milan, Mi, Italy
Ospedale San Gerardo - ASST Monza
🇮🇹Monza, Italy